Showing results (1-10 of 344) with videos related to
Sort By:
Pageof 35
Journal of Market Access & Health Policy|February 22, 2019
Estimation of the costs attributable to vitamin K antagonist treatment in patients with non-valvular atrial fibrillation from a French societal perspectivePierre Levy, David Smadja, Julie Dorey, et al.Journal of Market Access & Health Policy|November 15, 2018
Budget impact of antimicrobial wound dressings in the treatment of venous leg ulcers in the German outpatient care sector: a budget impact analysisMaria Gueltzow, Poroshat Khalilpour, Katharina Kolbe, et al.Journal of Market Access & Health Policy|September 7, 2019
Comparison of health technology assessment for new medicines in France and England: an example based on ixazomib for patients with relapsed or refractory multiple myelomaXavier Armoiry, Hans-Martin Spath, Aileen Clarke, et al.Journal of Market Access & Health Policy|September 7, 2019
Why "American Patients First" is likely to raise drug prices outside of the United StatesMonique Dabbous, Cyprien Milea, Steven Simoens, et al.Journal of Market Access & Health Policy|January 18, 2021
Economic evaluation of adverse events of dabrafenib plus trametinib versus nivolumab in patients with advanced BRAF-mutant cutaneous melanoma for adjuvant therapy in GermanyS Wahler, A Müller, C Koll, et al.Journal of Market Access & Health Policy|January 17, 2022
Psychometric validation of a patient-reported single-item assessment of 'Good Day Bad Day' in a neurogenic orthostatic hypotension population treated with droxidopaClément François, Nicola Germain, Renata Majewska, et al.Journal of Market Access & Health Policy|September 27, 2021
Bright line or lottery? On significance and value in medical decision makingJörg Mahlich, Srirangan DhebanJournal of Market Access & Health Policy|March 31, 2022
Cost-saving prediction model of transfer to palliative care for terminal cancer patients in a Japanese general hospitalYuki Hashimoto, Akitoshi Hayashi, Takashi Tonegawa, et al.Journal of Market Access & Health Policy|April 23, 2019
Government pharmaceutical pricing strategies in the Asia-Pacific region: an overviewNaina R Verghese, Jon Barrenetxea, Yukti Bhargava, et al.Journal of Market Access & Health Policy|June 4, 2019
Measuring the health-related quality of life in young children: how far have we come?Nicola Germain, Samuel Aballéa, Mondher ToumiPageof 35